PTK2 and lung cancer: Collectively, TM4SF4-derived signaling pathways including GSK3β/β-catenin and JAK2(or FAK)/STAT3 appear to be focused on the secretion level of OPN and thus strengthen EMT-associated CSC-like properties in lung cancer cells.